Alexandra Drakaki

An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis

Maria Hatziapostolou, Christos Polytarchou, Eleni Aggelidou et al. · Cell · 2011 · 448 citations · Full text

Hepatocellular Oncogenesis, Transcriptional Regulation, Liver Physiology +7

MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells

Jia Lee, Alexandra Drakaki, Dimitrios Iliopoulos et al. · Oncogene · 2011 · 160 citations · Full text

Mir-27b Targets Pparγ, Medicine, Immunology +9

Abstract CT011: A phase 1 multicenter study (TRAVERSE) evaluating the safety and efficacy of ALLO-316 following conditioning regimen in pts with advanced or metastatic clear cell renal cell carcinoma (ccRCC)

Samer A. Srour, Ritesh R. Kotecha, Brendan D. Curti et al. · Cancer Research · 2023 · 35 citations

Immunology, Immunoediting, Immunotherapeutics +19

Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1.

Arjun Vasant Balar, Matt D. Galsky, Yohann Loriot et al. · Journal of Clinical Oncology · 2016 · 31 citations

Advanced/metastatic Urothelial Carcinoma, Cancer Management, Imvigor210 Cohort 1 +25

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2023 · 26 citations · Full text

Urology, Genitourinary Cancer, Medicine +8